Mix & match. Save up to 25%. Shop now

Prime Peptides Retatrutide 10mg research vial

Retatrutide

฿3,320

Batch RT10-2609A

Size
Bundle & save up to 25%Mix & match. Every vial in your cart counts.

฿3,000 away from free shippingTracked post

Pay with

PromptPayKBankSCBBangkok BankKrungsriUSDTUSDCCash

10% off with crypto. How it works

Arrives tomorrow in BangkokBy Grab, every day. Paid and confirmed by 3 PM Bangkok time.
Rest of Thailand: Wed 4 – Thu 5 NovTracked post. Free shipping on orders from ฿3,000

The lab report for the vial you’ll get.

Every batch is tested by an independent lab before it goes on sale. Match the batch number on your vial to its report.

Retatrutide 10 mg

>99.80%Purity, HPLC
Batch
RT10-2609A
Net content
9.47 mg
Identity (HPLC)
Confirmed
Endotoxins
Pass
Lab
Vanguard Laboratory
Reported
16 Oct 2026
Report number
V261007-11 001
Verify at Vanguard

Tested by Vanguard LaboratoryDownload PDF

See all tests

Every Retatrutide test · 2 tests, newest first

What’s in the vial.

Retatrutide is a synthetic peptide studied as a triple-receptor (GIP / GLP-1 / glucagon) agonist in metabolic research.

For laboratory research use only
In this vial
10 mg lyophilized powder
CAS number
2381089-83-2
Store sealed
−20°C · protect from light
Once mixed
2-8°C · follow your lab protocol for how long

Three receptors. One research model.

Retatrutide is studied as a triple-receptor agonist across GIP, GLP-1 and glucagon signaling. This page describes the research literature; it does not provide clinical or medical guidance.

  • GLP-1

    Studied in models of insulin secretion and satiety signaling.

  • GIP

    Studied in models of insulin sensitivity and lipid handling.

  • Glucagon

    Studied in models of energy expenditure and lipolysis.

  • Balance

    Studied for how the three receptor signals interact.

Common questions

Research context, batch testing, storage and verification for Retatrutide.

What is Retatrutide (LY3437943)?

Retatrutide, also identified by the developmental code LY3437943, is a synthetic peptide investigated in published research as an agonist at the GIP, GLP-1 and glucagon receptors. Prime Peptides supplies it as a lyophilized material strictly for in-vitro laboratory research.

What is the molecular weight of Retatrutide?

Reference databases report a molecular weight of approximately 4,731 g/mol for Retatrutide. The Prime Peptides reference profile records 4,731.3 g/mol. This information is provided for compound identification and laboratory reference only.

How does Retatrutide differ from tirzepatide and semaglutide?

Published receptor pharmacology describes semaglutide as a GLP-1 receptor agonist, tirzepatide as a dual GIP and GLP-1 receptor agonist, and Retatrutide as a triple GIP, GLP-1 and glucagon receptor agonist. This is a comparison of receptor profiles reported in the research literature, not a claim of clinical equivalence or suitability.

How does Prime Peptides test Retatrutide?

Every batch goes through three layers of quality control. Our manufacturer runs its own QC and has its production independently tested by Janoshik Analytical. Then Vanguard or Janoshik tests every batch we stock again, for identity, HPLC purity, net content and endotoxins before we approve it for sale.

Every approved batch has its lab report on the Test Results page.

What purity standard does Prime Peptides use?

We target 99%+ purity by HPLC. The actual purity of each batch is measured independently and published in its lab report, so you can check the result yourself.

Scroll to Top